Drug Of Abuse Testing Services Market In-Depth Research On Basis Of Drug Type, Region And Forecast To 2028 : Grand View Research Inc.

San Francisco, 26 April 2023: The Report Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, LSD, Amphetamine & Methamphetamine), By Region, And Segment Forecasts, 2021 – 2028

The global drug of abuse testing services market size is expected to reach USD 3.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. The imposition of stringent laws mandating alcohol and illicit substance abuse testing is anticipated to drive the market during the forecast period. However, the violation of privacy rights while drug testing is considered a challenge and impedes the adoption of such testing services.

Workplace substance abuse is on the rise despite random tests being conducted by organizations. Commonly abused illicit drugs on the job are cannabis and cocaine. In the workplace, substance abuse might lead to significant loss of productivity, physical injuries, and even fatalities. On the basis of various drug abuse surveys, around 22.5% of people do not admit using alcohol or any illicit drugs during working hours. Around 1 in 10 respondents say that they come prepared to avoid the risk of random tests at the workplace. Therefore, there is a growing need for rapid and frequent drug of abuse testing at the workplace in order to minimize loss of productivity, absenteeism, and healthcare costs. However, with the COVID-19 crisis and subsequent lockdown scenarios throughout the world, people are staying at and working from home, which is expected to reduce the number of substance abuse cases at the workplace.

The National Institute on Drug Abuse (NIDA) has been established as one of the major federal agencies focused on supporting scientific research on drug use disorders and their consequences, thus improving public health. In March 2020, the NIDA issued a Notice of Special Interest (NOSI) highlighting the urgent need for research and data collection and analysis on the risks of COVID-19 infection in people suffering from substance use disorders. This pandemic is a potential threat to individuals who smoke tobacco or marijuana or try vaping, as the infection affects the lungs. This initiative aims at the submission of applications for Competitive Revisions to active grants, targeting research about SARS-CoV-2 infection risks in individuals with substance use disorders, especially with marijuana, nicotine, methamphetamine, and opioids.

Access Research Report of Drug Of Abuse Testing Services Market https://www.grandviewresearch.com/industry-analysis/drugs-abuse-testing-services-market

Drug Of Abuse Testing Services Market Report Highlights

  • By drug type, cannabis/marijuana accounted for the largest market share in 2020. This can be attributed to the growing usage of cannabis across the world, especially in the U.S.
  • The opioids drug type segment held a significant revenue share in 2020 due to the growing cultivation and trading of opioids in Asian countries and a rise in related overdose deaths
  • North America accounted for the largest market share in 2020 due to the highest consumption of illicit drugs in the U.S. as well as the imposition of various drug policies mandating drug screening in the country
  • Latin America is anticipated to witness the fastest growth during the forecast period owing to the increasing usage and trading of illegal drugs
  • COVID-19 has led to a significant rise in alcohol and other substance abuse globally; however, demand for drug testing has declined due to the increased focus on measures to combat the pandemic

List of Key Players of Drug Of Abuse Testing Services Market

  • Quest Diagnostics
  • Abbott Laboratories
  • Clinical Reference Laboratory (CRL), Inc.
  • Laboratory Corporation of America Holdings
  • Cordant Health Solutions
  • Legacy Medical Services
  • DrugScan
  • Omega Laboratories, Inc.
  • Psychemedics Corporation
  • Millennium Health
  • Mayo Clinic Laboratories
  • Precision Diagnostics
  • American Substance Abuse Professionals, (ASAP) Inc.
  • United States Drug Testing Laboratories (USDTL), Inc.
  • LGC Group

Access Press Release of Drug Of Abuse Testing Services Market @ https://www.grandviewresearch.com/press-release/global-drugs-abuse-testing-services-market 

Drug Of Abuse Testing Services Market Size Is Poised To Reach USD 3.8 Billion By 2028: Grand View Research Inc.

San Francisco, 25 Feb 2021: The Report Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, LSD, Amphetamine & Methamphetamine), By Region, And Segment Forecasts, 2021 – 2028

The global drug of abuse testing services market size is expected to reach USD 3.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. The imposition of stringent laws mandating alcohol and illicit substance abuse testing is anticipated to drive the market during the forecast period. However, the violation of privacy rights while drug testing is considered a challenge and impedes the adoption of such testing services.

Workplace substance abuse is on the rise despite random tests being conducted by organizations. Commonly abused illicit drugs on the job are cannabis and cocaine. In the workplace, substance abuse might lead to significant loss of productivity, physical injuries, and even fatalities. On the basis of various drug abuse surveys, around 22.5% of people do not admit using alcohol or any illicit drugs during working hours. Around 1 in 10 respondents say that they come prepared to avoid the risk of random tests at the workplace. Therefore, there is a growing need for rapid and frequent drug of abuse testing at the workplace in order to minimize loss of productivity, absenteeism, and healthcare costs. However, with the COVID-19 crisis and subsequent lockdown scenarios throughout the world, people are staying at and working from home, which is expected to reduce the number of substance abuse cases at the workplace.

The National Institute on Drug Abuse (NIDA) has been established as one of the major federal agencies focused on supporting scientific research on drug use disorders and their consequences, thus improving public health. In March 2020, the NIDA issued a Notice of Special Interest (NOSI) highlighting the urgent need for research and data collection and analysis on the risks of COVID-19 infection in people suffering from substance use disorders. This pandemic is a potential threat to individuals who smoke tobacco or marijuana or try vaping, as the infection affects the lungs. This initiative aims at the submission of applications for Competitive Revisions to active grants, targeting research about SARS-CoV-2 infection risks in individuals with substance use disorders, especially with marijuana, nicotine, methamphetamine, and opioids.

Access Research Report of Drug Of Abuse Testing Services Market https://www.grandviewresearch.com/industry-analysis/drugs-abuse-testing-services-market

Drug Of Abuse Testing Services Market Report Highlights

  • By drug type, cannabis/marijuana accounted for the largest market share in 2020. This can be attributed to the growing usage of cannabis across the world, especially in the U.S.
  • The opioids drug type segment held a significant revenue share in 2020 due to the growing cultivation and trading of opioids in Asian countries and a rise in related overdose deaths
  • North America accounted for the largest market share in 2020 due to the highest consumption of illicit drugs in the U.S. as well as the imposition of various drug policies mandating drug screening in the country
  • Latin America is anticipated to witness the fastest growth during the forecast period owing to the increasing usage and trading of illegal drugs
  • COVID-19 has led to a significant rise in alcohol and other substance abuse globally; however, demand for drug testing has declined due to the increased focus on measures to combat the pandemic

List of Key Players of Drug Of Abuse Testing Services Market

  • Quest Diagnostics
  • Abbott Laboratories
  • Clinical Reference Laboratory (CRL), Inc.
  • Laboratory Corporation of America Holdings
  • Cordant Health Solutions
  • Legacy Medical Services
  • DrugScan
  • Omega Laboratories, Inc.
  • Psychemedics Corporation
  • Millennium Health
  • Mayo Clinic Laboratories
  • Precision Diagnostics
  • American Substance Abuse Professionals, (ASAP) Inc.
  • United States Drug Testing Laboratories (USDTL), Inc.
  • LGC Group

Access Press Release of Drug Of Abuse Testing Services Market @ https://www.grandviewresearch.com/press-release/global-drugs-abuse-testing-services-market

Drug of Abuse Testing Services Market Size Worth $ 2.9 Billion By 2025: Grand View Research Inc.

Drug of Abuse Testing Services Market

San Francisco, 14 Oct 2020: The Report Drug of Abuse Testing Services Market Size, Share & Trends Analysis Report By Type (Alcohol, Cannabis, Cocaine, Opioids, Amphetamine, LSD), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2025

The global drug of abuse testing services market size is expected to reach USD 2.9 billion by 2025, according to a new report by Grand View Research, Inc. Increase in demand for therapy for substance abuse is one of the crucial factors anticipated to boost the market. According to World Drug Report 2016, annually, treatments for drug abuse are accessible to only 17% of the total drug abusers. In North American, Eastern & Southeastern Europe, and Asia, opioid is one of the major drugs of concern.

According to World Drug Report 2016, 1 in every 20 people aged 15 to 64 consumed at least one drug in 2014. More than 29 million people who abuse drugs are estimated to suffer from drug-related disorders. There are 12 million people that abuse drugs, out of whom 14% are suffering from HIV. Cannabis and amphetamine are some of the highly abused drugs globally. Approximately 183 million people used cannabis in 2014. Stringent regulations for drug abuse testing at workplaces, such as Omnibus Transportation Employee Testing Act of 1991, etc., are expected to increase demand for screening kits over the forecast period.

Morbidity and mortality due to drug abuse are rising globally. One in every 4 deaths is attributed to tobacco, alcohol, and illicit drug consumption. The overdose of opioids results in adverse and serious health conditions. In the U.S., the nonmedical use of prescription opioids has considerably increased. According to statistics reported by National Institute of Drug Abuse, overdose of opioids results in more than 90 deaths every day in the U.S. The rise in prevalence of comorbidities associated with substance abuse, such as HIV and hepatitis C, have resulted in increase in demand for screening procedures. Furthermore, increase in the number of government initiatives to control illicit drugs and alcohol usage and rise in number of treatment alternatives are also driving the market.

Access Research Report of Drug of Abuse Testing Services Market https://www.grandviewresearch.com/industry-analysis/drugs-abuse-testing-services-market

Drug of Abuse Testing Services Market Report Highlights

  • The global drug of abuse testing services market size was estimated at USD 1,465.4 million in 2016 and is expected to grow at a CAGR of 8.1% from 2017 to 2025
  • Cannabis emerged as the largest drug type segment and the opioids segment is anticipated to witness fastest growth over the next 8 years
  • The North America region accounted for the largest market share in 2016 due to increased usage of medical marijuana, increased usage of investigational testing, and rise in number of toxicology laboratories.
  • Asia Pacific is anticipated to witness lucrative growth over the next decade due to increase in alcohol consumption and related disorders in this region
  • The market is highly consolidated in the U.S., with Laboratory Corporation of America Holdings; Alere; United States Drug Testing Laboratories, Inc. (USDTL); Quest Diagnostics, Inc. holding 85% market share.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the drug of abuse testing services market on the basis of drug type and region:

Drug of Abuse Testing Services Drug Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Alcohol
  • Cannabis
  • Cocaine
  • Opioids
  • Amphetamine
  • LSD

Drug of Abuse Testing Services Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Drug of Abuse Testing Services Market @ https://www.grandviewresearch.com/press-release/global-drugs-abuse-testing-services-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

Design a site like this with WordPress.com
Get started